| Dr Joshua James Faucher, MD | |
|
21601 76th Ave W, Edmonds, WA 98026-7507 | |
| (425) 640-4000 | |
| Not Available |
| Full Name | Dr Joshua James Faucher |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 8 Years |
| Location | 21601 76th Ave W, Edmonds, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407206188 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 036-149264 (Illinois) | Secondary |
| 207P00000X | Emergency Medicine | MD61291931 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Swedish Edmonds Hospital | Edmonds, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America Llc | 6608056171 | 575 |
News Archive
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
The National Council for Community Behavioral Healthcare (National Council) today announced a new eight-month pilot program designed to advance standards of care for people living with schizophrenia. This initiative at 10 community behavioral health organizations nationwide is designed to improve the daily functioning of people with schizophrenia and raise expectations for what is achievable.
Laboratory Corporation of America Holdings, today announced that it has entered into a definitive agreement under which LabCorp will acquire Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.
In the chaotic healthcare situation caused by the novel coronavirus disease COVID-19, it has been challenging to estimate the actual severity of the disease. However, it is a crucial bit of information for those who form healthcare and economic policies.
› Verified 6 days ago
| Entity Name | North Sound Emergency Medicine Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114937919 PECOS PAC ID: 5496646754 Enrollment ID: O20040324000729 |
News Archive
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
The National Council for Community Behavioral Healthcare (National Council) today announced a new eight-month pilot program designed to advance standards of care for people living with schizophrenia. This initiative at 10 community behavioral health organizations nationwide is designed to improve the daily functioning of people with schizophrenia and raise expectations for what is achievable.
Laboratory Corporation of America Holdings, today announced that it has entered into a definitive agreement under which LabCorp will acquire Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.
In the chaotic healthcare situation caused by the novel coronavirus disease COVID-19, it has been challenging to estimate the actual severity of the disease. However, it is a crucial bit of information for those who form healthcare and economic policies.
› Verified 6 days ago
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447484274 PECOS PAC ID: 6608056171 Enrollment ID: O20130213000571 |
News Archive
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
The National Council for Community Behavioral Healthcare (National Council) today announced a new eight-month pilot program designed to advance standards of care for people living with schizophrenia. This initiative at 10 community behavioral health organizations nationwide is designed to improve the daily functioning of people with schizophrenia and raise expectations for what is achievable.
Laboratory Corporation of America Holdings, today announced that it has entered into a definitive agreement under which LabCorp will acquire Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.
In the chaotic healthcare situation caused by the novel coronavirus disease COVID-19, it has been challenging to estimate the actual severity of the disease. However, it is a crucial bit of information for those who form healthcare and economic policies.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua James Faucher, MD 21601 76th Ave W, Edmonds, WA 98026-7507 Ph: (425) 640-4000 | Dr Joshua James Faucher, MD 21601 76th Ave W, Edmonds, WA 98026-7507 Ph: (425) 640-4000 |
News Archive
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration invite scientists from academia and the biotechnology industry worldwide to apply for research grants to develop Frontotemporal Dementia (FTD)-specific biomarkers that reflect pathological and clinical differences so that appropriate patients can be selected for clinical trials and responses to investigational treatments can be monitored.
The National Council for Community Behavioral Healthcare (National Council) today announced a new eight-month pilot program designed to advance standards of care for people living with schizophrenia. This initiative at 10 community behavioral health organizations nationwide is designed to improve the daily functioning of people with schizophrenia and raise expectations for what is achievable.
Laboratory Corporation of America Holdings, today announced that it has entered into a definitive agreement under which LabCorp will acquire Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.
In the chaotic healthcare situation caused by the novel coronavirus disease COVID-19, it has been challenging to estimate the actual severity of the disease. However, it is a crucial bit of information for those who form healthcare and economic policies.
› Verified 6 days ago
Dr. Bryce Curtis Inman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 | |
Dr. Raul Borromeo, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4100 | |
Katherine Bryant, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4682 | |
Dr. Robert Rutherford, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4682 | |
Mr. Thomas James Swanson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4000 | |
Dr. Robert Adelman, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 21601 76th Ave W, Edmonds, WA 98026 Phone: 425-640-4682 Fax: 425-640-4105 |